Read on Twitter
Here’s why a COVID-19 vaccine could end up costing you a small fortune.
From @Davidlaz: https://www.latimes.com/business/story/2020-04-21/column-coronavirus-drug-pricing
From @Davidlaz: https://www.latimes.com/business/story/2020-04-21/column-coronavirus-drug-pricing
When you’re pricing a drug relative to its “benefits,” rather than its actual production cost, you can charge as much as you like. This is why a vial of insulin that sold for $20 a quarter-century ago now sells for about $300.
More from @Davidlaz: https://www.latimes.com/business/story/2020-04-21/column-coronavirus-drug-pricing
More from @Davidlaz: https://www.latimes.com/business/story/2020-04-21/column-coronavirus-drug-pricing
Perhaps the most notorious was Turing Pharmaceuticals buying the rights in 2015 to Daraprim, which is used to treat infections.
The company raised the price overnight from $13.50 to $750 a pill https://www.latimes.com/business/la-fi-senate-drug-price-study-20161221-story.html
The company raised the price overnight from $13.50 to $750 a pill https://www.latimes.com/business/la-fi-senate-drug-price-study-20161221-story.html
Two key takeaways here from @Davidlaz about what you might expect from a COVID-19 vaccine.
Comments are open on his story. Share your thoughts with us: https://www.latimes.com/business/story/2020-04-21/column-coronavirus-drug-pricing
Comments are open on his story. Share your thoughts with us: https://www.latimes.com/business/story/2020-04-21/column-coronavirus-drug-pricing
